Emergent Biosolutions VP of Investor Relations Salaries in Washington, DC | Comparably
Emergent Biosolutions Claimed Company
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. read more
EMPLOYEE
PARTICIPANTS
22
TOTAL
RATINGS
390
HR or Marketing? Claim Your Free Employer Account

Emergent Biosolutions VP of Investor Relations Salaries in Washington, DC

The average Emergent Biosolutions VP of Investor Relations in Washington, DC earns an estimated $128,525 annually. Emergent Biosolutions' VP of Investor Relations compensation is $2,883 less than the US average for a VP of Investor Relations.

In Washington, DC, The Communications Department at Emergent Biosolutions earns null less on average than the null Department.

Last updated 3 years ago.

$77k
$120k
$129k
$225k
$128,525
Average Compensation
$128,525
avg. base

VP of Investor Relations Salaries at Emergent Biosolutions

In Washington, DC, VPs of Investor Relations earn $67,025 more than Editors.

$62k
* estimated salary

Compensation at Emergent Biosolutions by Department

In Washington, DC, The Communications Department averages $2,993 less than the Admin Department.

Customer Support
$61,153 Avg. total comp.
+$6k
Admin
$57,993 Avg. total comp.
+$3k
Communications
$55,000 Avg. total comp.

How VPs of Investor Relations at Emergent Biosolutions Rate Their Compensation

The majority of VPs of Investor Relations at Emergent Biosolutions believe they're compensated fairly. 33% of VPs of Investor Relations at Emergent Biosolutions say they receive annual bonuses, and the vast majority (88%) are satisfied with their benefits. See more compensation ratings at Emergent Biosolutions

×
Rate your company